Welcome to our dedicated page for Taoweave news (Ticker: TWAV), a resource for investors and traders seeking the latest updates and insights on Taoweave stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Taoweave's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Taoweave's position in the market.
TaoWeave (Nasdaq: TWAV) began trading under the new ticker TWAV on December 10, 2025, replacing its prior symbol OBLG. The company also launched a new investor website at www.taoweave.ai that displays real-time treasury and valuation metrics, including TAO holdings, estimated treasury value, market capitalization, and mNAV ratio.
On November 12, 2025 TaoWeave reported holdings of 21,943 TAO (~$8.0 million at the UTC close); over the last 30 days the company increased holdings to 24,382 TAO, reflecting continued execution of its TAO-exclusive treasury strategy. The ticker change does not affect legal name, structure, or reporting, and no shareholder action is required.